FLOUXITINE VS. ACETAMINOPHEN IN DEVELOPING ANIMAL AUTISM MODEL: A COMPARATIVE ANALYSIS

Main Article Content

Sarah Jameel KHAN
Shadab Ahmed
Sidra Siddiqui
Farzana Sadaf
Hina Ilyas
Sana Siddiqui
Hira Ahmed
Aatka Ali

Keywords

autism spectrum disorder, Negative geotaxis,, Surface righting reflex, Nest seeking, swimming performance

Abstract

Abstract


Background: Autism Spectrum Disorder (ASD) includes difficulties in social interaction, communication, and the presence of repetitive behaviors and interests. While the mechanism of ASD remains unclear, a combination of genetic and environmental factors, alongside disruptions in neurotransmission systems, might play significant role in its pathophysiology.


Objective: This study compares the effectiveness of fluoxetine and acetaminophen in developing animal models of autism, providing insights into which drug better elicits ASD-like behaviors.


Methodology: Three groups of Wistar Rats were used in study. Saline group, fluoxetine (FLX) and Acetaminophen(ACET) in which changes in developmental parameters were assessed by comparing body weight, length and eye opening according to standardized protocol. While behavioral assessment tests includes negative geotaxis, surface righting, nest seeking response, forelimb grip strength and swimming performance.


Results: In current study, highly significant changes were observed in motor function of FLX group in negative geotaxis test at PND 6 and 10. However, in surface righting reflex ACET group displayed significant improvement in re-orientation time at PND 9. In battery tests like nest seeking, swimming and forelimb grip strength test FLX group take more time to compete their task as compare to control, while ACET exhibited significant increase in time to perform forelimb grip strength task.


Conclusion: In conclusion, while fluoxetine may exhibit greater efficacy in inducing autism-like behaviors in animal models however it’s chronic and high-dose usage elevated morbidity and mortality rates. Conversely, acetaminophen may offer a safer alternative.

Abstract 122 | pdf Downloads 68

References

1. Alemany, S., Avella-García, C., Liew, Z., García-Esteban, R., Inoue, K., Cadman, T., ... & Sunyer, J. (2021). Prenatal and postnatal exposure to acetaminophen in relation to autism spectrum and attention-deficit and hyperactivity symptoms in childhood: Meta-analysis in six European population-based cohorts. European journal of epidemiology, 36(10), 993-1004.
2. Ali, Z., & Bhaskar, S. B. (2016). Basic statistical tools in research and data analysis. Indian journal of anaesthesia, 60(9), 662-669.
3. Anshu, K., Nair, A. K., Srinath, S., & Laxmi, T. R. (2023). Altered Developmental Trajectory in Male and Female Rats in a Prenatal Valproic Acid Exposure Model of Autism Spectrum Disorder. Journal of autism and developmental disorders, 53(11), 4390-4411.
4. Arzuaga, A. L., Edmison, D. D., Mroczek, J., Larson, J., & Ragozzino, M. E. (2023). Prenatal stress and fluoxetine exposure in mice differentially affect repetitive behaviors and synaptic plasticity in adult male and female offspring. Behavioural Brain Research, 436, 114114.
5. Blecharz-Klin, K., Joniec-Maciejak, I., Jawna, K., Pyrzanowska, J., Piechal, A., Wawer, A., & Widy-Tyszkiewicz, E. (2015). Effect of prenatal and early life paracetamol exposure on the level of neurotransmitters in rats—Focus on the spinal cord. International Journal of Developmental Neuroscience, 47, 133-139.
6. Bhat, R. S., Alonazi, M., Al-Daihan, S., & El-Ansary, A. (2023). Prenatal SSRI Exposure Increases the Risk of Autism in Rodents via Aggravated Oxidative Stress and Neurochemical Changes in the Brain. Metabolites, 13(2), 310.
7. Campisi, L., Imran, N., Nazeer, A., Skokauskas, N., & Azeem, M. W. (2018). Autism spectrum disorder. British medical bulletin, 127(1), 91-100.
8. de Castro, C. T., Pereira, M., & Dos Santos, D. B. (2022). Association between paracetamol use during pregnancy and perinatal outcomes: Prospective NISAMI cohort. PloS one, 17(4), e0267270.

9. Ghanem, C. I., Pérez, M. J., Manautou, J. E., & Mottino, A. D. (2016). Acetaminophen from liver to brain: New insights into drug pharmacological action and toxicity. Pharmacological research, 109, 119-131.
10. Glover, M. E., & Clinton, S. M. (2016). Of rodents and humans: A comparative review of the neurobehavioral effects of early life SSRI exposure in preclinical and clinical research. International Journal of Developmental Neuroscience, 51, 50-72.
11. Harper, K. M., Nikolova, V. D., Conrad, M. E., & Moy, S. S. (2022). Neonatal Behavioral Screen for Mouse Models of Neurodevelopmental Disorders. In Microcephaly: Methods and Protocols (pp. 159-173). New York, NY: Springer US.
12. Handal, M., Skurtveit, S., Furu, K., Hernandez‐Diaz, S., Skovlund, E., Nystad, W., & Selmer, R. (2016). Motor development in children prenatally exposed to selective serotonin reuptake inhibitors: a large population‐based pregnancy cohort study. BJOG: An International Journal of Obstetrics & Gynaecology, 123(12), 1908-1917.
13. Hutchison, S. M., Mâsse, L. C., Pawluski, J. L., & Oberlander, T. F. (2018). Perinatal selective serotonin reuptake inhibitor (SSRI) effects on body weight at birth and beyond: A review of animal and human studies. Reproductive toxicology, 77, 109-121.
14. Kroeze, Y., Dirven, B., Janssen, S., Kröhnke, M., Barte, R. M., Middelman, A., ... & Homberg, J. R. (2016). Perinatal reduction of functional serotonin transporters results in developmental delay. Neuropharmacology, 109, 96-111.
15. Millard, S. J. (2019). The effects of perinatal Fluoxetine treatment on offspring behaviour and neurobiology.
16. Parker, W., Hornik, C. D., Bilbo, S., Holzknecht, Z. E., Gentry, L., Rao, R., ... & Nevison, C. D. (2017). The role of oxidative stress, inflammation and acetaminophen exposure from birth to early childhood in the induction of autism. Journal of International Medical Research, 45(2), 407-438.
17. Rigobello, C., Klein, R. M., Debiasi, J. D., Ursini, L. G., Michelin, A. P., Matsumoto, A. K., ... & Moreira, E. G. (2021). Perinatal exposure to paracetamol: Dose and sex-dependent effects in behaviour and brain’s oxidative stress markers in progeny. Behavioural brain research, 408, 113294.
18. Ruhela, R. K., Soni, S., Sarma, P., Prakash, A., & Medhi, B. (2019). Negative geotaxis: An early age behavioral hallmark to VPA rat model of autism. Annals of neurosciences, 26(1), 25-31.
19. Schneider, T., & Przewłocki, R. (2005). Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology, 30(1), 80-89.
20. Sunand, K., Mohan, G. K., & Bakshi, V. (2020). Supplementation of lactobacillus probiotic strains supports gut-brain-axis and defends autistic deficits occurred by valproic acid-induced prenatal model of autism. Pharmacognosy Journal, 12(6s).
21. Svirsky, N., Levy, S., & Avitsur, R. (2016). Prenatal exposure to selective serotonin reuptake inhibitors (SSRI) increases aggression and modulates maternal behavior in offspring mice. Developmental Psychobiology, 58(1), 71-82.
22. A Taqa, G., A Al-Sheikh, H., & I Al-Allaf, L. (2021). Effects of Melatonin on Behavioural Activities in Acetaminophen-induced Autism in Rat. Journal of Applied Veterinary Sciences, 6(4), 58-66.
23. Tovo-Rodrigues, L., Schneider, B. C., Martins-Silva, T., Del-Ponte, B., Loret de Mola, C., Schuler-Faccini, L., ... & Bertoldi, A. D. (2018). Is intrauterine exposure to acetaminophen associated with emotional and hyperactivity problems during childhood? Findings from the 2004 Pelotas birth cohort. BMC psychiatry, 18, 1-11.
24. Veenstra-VanderWeele, J., O’Reilly, K. C., Dennis, M. Y., Uribe-Salazar, J. M., & Amaral, D. G. (2023). Translational Neuroscience approaches to understanding autism. American Journal of Psychiatry, 180(4), 265-276.
25. Zhao, J. P., Murata, Y., & Constantine-Paton, M. (2013). Eye opening and PSD95 are required for long-term potentiation in developing superior colliculus. Proceedings of the National Academy of Sciences, 110(2), 707-712.